Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.21M-4.3% | $31.58M-18.0% | $38.49M+9.7% | $35.08M-17.4% | $42.45M+39.5% | ||
| $169.31M-9.7% | $187.55M-1.4% | $190.2M— | —— | —— | ||
| $55.8M+13.6% | $49.11M+11.6% | $43.99M— | —— | —— | ||
| $83.15M+10.6% | $75.15M+12.6% | $66.75M+32.7% | $50.3M+36.4% | $36.87M+56.6% | ||
| $247.99M-7.4% | $267.91M-0.8% | $270.03M— | —— | —— | ||
| $10.16M+18.1% | $8.6M+16.5% | $7.39M— | —— | —— | ||
| $304.42M-7.4% | $328.74M-0.4% | $330.05M— | —— | —— | ||
| $15.2M-7.0% | $16.34M+15.1% | $14.19M+44.3% | $9.84M+31.6% | $7.47M+68.7% | ||
| $3.35M+1.6% | $3.3M+10.4% | $2.99M— | —— | —— | ||
| $23.19M-25.0% | $30.92M+21.8% | $25.39M— | —— | —— | ||
| $33.17M-19.4% | $41.13M+16.6% | $35.29M— | —— | —— | ||
| $5K+25.0% | $4K0.0% | $4K— | —— | —— | ||
| -$391.83M-5.9% | -$369.94M-3.8% | -$356.47M— | —— | —— | ||
| $271.25M-5.7% | $287.61M-2.4% | $294.76M-2.3% | $301.63M-3.9% | $313.75M+228% | ||
| $304.42M-7.4% | $328.74M-0.4% | $330.05M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's total assets?
- Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
- How much debt does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
- Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 10.69 — current assets exceed current liabilities.
- Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
